UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?

World journal of hepatology, 2015-09, Vol.7 (19), p.2184-2188

Lanthier, Nicolas

2015

Volltextzugriff (PDF)

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

The New England journal of medicine, 2021-10, Vol.385 (17), p.1547-1558

2021

Volltextzugriff (PDF)

Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?

Cells (Basel, Switzerland), 2022-08, Vol.11 (17), p.2718

2022

Volltextzugriff (PDF)

Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome

Clinical science (1979), 2015-12, Vol.129 (11), p.933-949

2015

Volltextzugriff (PDF)

Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation

The Journal of biological chemistry, 2010-10, Vol.285 (44), p.33652-33661

2010

Volltextzugriff (PDF)

Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individuals

BMC medicine, 2022-03, Vol.20 (1), p.110-110, Article 110

2022

Volltextzugriff (PDF)

Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients

Scientific reports, 2021-01, Vol.11 (1), p.659-659, Article 659

2021

Volltextzugriff (PDF)

Kupffer cell activation is a causal factor for hepatic insulin resistance

American journal of physiology: Gastrointestinal and liver physiology, 2010-01, Vol.298 (1), p.G107-G116

2010

Volltextzugriff (PDF)

Adipose tissues as endocrine target organs

Baillière's best practice & research. Clinical gastroenterology, 2014-08, Vol.28 (4), p.545-558

2014

Volltextzugriff (PDF)

Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial

PloS one, 2013-01, Vol.8 (1), p.e53719

2013

Volltextzugriff (PDF)

Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?

Stem cell research & therapy, 2017-04, Vol.8 (1), p.88-88, Article 88

2017

Volltextzugriff (PDF)

Liver Fetuin-A at Initiation of Insulin Resistance

Metabolites, 2022-10, Vol.12 (11), p.1023

2022

Volltextzugriff (PDF)

What references and what gold standard should be used to assess myosteatosis in chronic liver disease?

Journal of hepatology, 2024-07

2024

Volltextzugriff (PDF)

Pirfenidone-induced liver injury, a case report of a rare idiosyncratic reaction

Therapeutic advances in drug safety, 2024-01, Vol.15, p.20420986241270866

2024

Volltextzugriff (PDF)

A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients

JHEP reports, 2021-08, Vol.3 (4), p.100323-100323, Article 100323

2021

Volltextzugriff (PDF)

Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis

Alimentary pharmacology & therapeutics, 2022-04, Vol.55 (7), p.889-890

2022

Volltextzugriff (PDF)

Publisher Correction: Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients

Scientific reports, 2021-03, Vol.11 (1), p.6123-6123, Article 6123

2021

Volltextzugriff (PDF)

Fetuin-A in Activated Liver Macrophages Is a Key Feature of Non-Alcoholic Steatohepatitis

Metabolites, 2022-07, Vol.12 (7), p.625

2022

Volltextzugriff (PDF)

Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations

Frontiers in nutrition (Lausanne), 2022-11, Vol.9, p.1051157-1051157

2022

Volltextzugriff (PDF)

Regorafenib induced severe toxic hepatitis: characterization and discussion

Liver international, 2016-11, Vol.36 (11), p.1590-1594

2016

Volltextzugriff (PDF)

Evaluation of a Ten-Antigen Immunodot Test in Autoimmune Hepatitis and Primary Biliary Cholangitis: Lessons Learned for a Tertiary Care Academic Hospital

Diagnostics (Basel), 2024-08, Vol.14 (17), p.1882

2024

Volltextzugriff (PDF)

Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia

Journal of cachexia, sarcopenia and muscle, 2023-06, Vol.14 (3), p.1569-1582

2023

Volltextzugriff (PDF)

Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis

Hepatology communications, 2021-04, Vol.5 (4), p.618-628

2021

Volltextzugriff (PDF)

Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis

Hepatology communications, 2019-07, Vol.3 (7), p.867-882

2019

Volltextzugriff (PDF)

Les nouveaux traitements de la stéatohépatite non-alcoolique

Nutrition clinique et métabolisme, 2020-10, Vol.34 (3), p.216-222

Lanthier, Nicolas

2020

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(107)

Publikationsform

Artikel
(117)
Berichte
(2)

Sprache

Englisch
(115)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?

Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome

Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation

Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individuals

Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients

Kupffer cell activation is a causal factor for hepatic insulin resistance

Adipose tissues as endocrine target organs

Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial

Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?

Liver Fetuin-A at Initiation of Insulin Resistance

What references and what gold standard should be used to assess myosteatosis in chronic liver disease?

Pirfenidone-induced liver injury, a case report of a rare idiosyncratic reaction

A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients

Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis

Publisher Correction: Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients

Fetuin-A in Activated Liver Macrophages Is a Key Feature of Non-Alcoholic Steatohepatitis

Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations

Regorafenib induced severe toxic hepatitis: characterization and discussion

Evaluation of a Ten-Antigen Immunodot Test in Autoimmune Hepatitis and Primary Biliary Cholangitis: Lessons Learned for a Tertiary Care Academic Hospital

Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia

Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis

Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis

Les nouveaux traitements de la stéatohépatite non-alcoolique

Suchergebnisse filtern